Greater Expression of Transforming Growth Factor α and Proliferating Cell Nuclear Antigen Staining in Mouse Hepatoblastomas Than Hepatocellular Carcinomas Induced by a Diethylnitrosamine-Sodium Phenobarbital Regimen

Abstract

Transforming growth factor α (TGF-α) is a potent stimulator of normal hepatocyte proliferation, considered to have relationship to the liver regeneration or carcinogenesis. In this study, we investigated immunohistochemically the association between expression of TGF-α and cell proliferation activity in mouse hepatoblastoma s (HBs) and hepatocellular carcinomas (HCCs) induced in B6C3F1 mice by diethylnitrosamine and sodium phenobarbital. The TGF-α-positive rate in HBs (29.2%) was significantly higher than that in HCCs (12.7%). Likewise, the proliferating cell nuclear antigen-positive rate (22.2%) was higher than the HCC value (14.5%). On the individual data for both TGF-α and PCNA, most of the HBs showed higher positive rates than HCCs. In HBs, TGF-α was localized only in the nuclei, whereas some HCC cells stained positive both in their nuclei and cytoplasm (0.6%). These results suggest expression of TGF-α and its localization might be linked to cell proliferation and play a role in malignant progression of mouse HBs.

Keywords

B6C3F1 mice cell proliferation hepatoblastoma immunohistochemistry liver transforming growth factor α.

References

Brown PI , Lam R. , Lakshmanan J. , Fisher DA (1990). Transforming growth factor alpha in developing rats. Am J Physiol 259: E256—260.

Calvert RJ , Tashiro Y. , Buzard GS , Diwan BA , Weghorst CM (1995). Lack of p53 point mutations in chemically induced mouse hepatoblastomas: An end-stage, highly malignant hepatocellular tumor . Cancer Lett 95: 175—180.

Derynck R. (1988). Transforming growth factor α. Cell 54: 593—595.

Derynck R. , Goeddel DV , Ullrich A. , Gutterman JU , Williams RD , Bringman TS , Berger WH (1987). Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707—712.

Diwan BA , Henneman JR , Rice JM ( 1995). Further evidence for promoter-dependent development of hepatoblastoma in the mouse. Cancer Lett 89: 29—35.

Diwan BA , Ward JM , Rice JM ( 1989). Promotion of malignant `embryonal' liver tumors by phenobarbital: Increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6) F1 mice initiated with N-nitrosodiethylamine. Carcinogenesis 10: 1345—1348.

Diwan BA , Ward JM , Rice JM ( 1992). Origin and pathology of hepatoblastoma in mice. In: The Role of Cell Types in Hepatocarcinogenesi s, Sirica AE (ed). CRC Press, Boca Raton, FL, pp 71—78.

Harada T. , Enomoto A. , Boorman GA , Maronpot RR (1999). Liver and gall-bladder. In: Pathology of the Mouse, Maronpot RR (ed). Cache River Press, Vienna, IL, pp 119—183.

Hsia CC , Axiotis CA , Di Bisceglie AM , Tabor E. (1992). Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver . Cancer 70: 1049—1056.

10.

Imai T. , Tashiro T. , Hayakawa K. , Nakanowatari J. , Fukuta T. , Hosokawa S. , Tsukamoto T. , Inada K. , Tatematsu M. (1998). Stable expression of glutathione S-transferase P-form mRNA and TGF-α immunohistochemical expression are useful markers for identification of persistent nodules from an early stage in rat hepatocarcinogenesis . J Toxicol Pathol 11: 249—255.

11.

Imamura T. , Oka S. , Tanahashi T. , Okita Y. (1994). Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp Cell Res 215: 363— 372.

12.

Jhappan C. , Stahle C. , Harkins RN , Fausto N. , Smith GH , Merlino GT (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas . Cell 61: 1137— 1146.

13.

Kaufmann WK , Byrd LL , Palmieri D. , Nims RW , Rice JM (1997). TGF-α sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes. Carcinogenesis 18: 1381—1387.

14.

Kira S. , Nakanishi T. , Suemori S. , Kitamoto M. , Watanabe Y. , Kajiyama G. (1997). Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver 17: 177— 182.

15.

Kiss A. , Szepesi A. , Lotz G. , Nagy P. , Schaff Z. (1998). Expression of transforming growth factor-α in hepatoblastoma. Cancer 83: 690—697.

16.

Kobayashi K. , Kusakabe M. , Okada M. , Sakairi T. , Goto K. , Tsuchiya T. , Sugimoto J. , Sano F. , Mutai M. (2000). Immunohistochemical localization of transforming growth factor alpha in chemically induced rat hepatocellular carcinomas with reference to differentiation and proliferation. Toxicol Pathol 28: 664—667.

17.

Kojima T. , Mutai M. , Sawada N. , Zhong Y. , Oyamada M. , Mori M. ( 1993). Histopathological studies of mouse hepatoblastoma induced by DEN. J Toxicol Pathol 6 (Suppl): 21—28.

18.

Lee GH , Merlino G. , Fausto N. (1992). Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 52: 5162—5170.

19.

LiuC. , Tsao MS , Grisham JW (1988). Transforming growthfactors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Cancer Res 48: 850—855.

20.

Luetteke NC , Michalopoulos GK , Teixidó J. , Gilmore R. , Massagué J. , Lee DC (1988). Characterization of high molecular weight transforming growth factor α produced by rat hepatocellular carcinoma cells. Biochemistry 27: 6487—6494.

21.

Marti U. , Burwen SJ , Jones AL (1989). Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update. Hepatology 9: 126—138.

22.

Mead JE , Fausto N. (1989). Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558—1562.

23.

Morimitsu Y. , Hsia CC , Kojiro M. , Tabor E. (1995). Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: Relative expression of transforming growth factor-α and its receptor in the different areas of tumor. Hum Pathol 26: 1126—1132.

24.

Nonoyama T. , Fullerton F. , Reznik G. , Bucci TJ , Ward JM (1988). Mouse hepatoblastomas: A histologic, ultrastructural, and immunohistochemical study. Vet Pathol 25: 286—296.

25.

Sandgren EP , Luetteke NC , Palmiter RD , Brinster RL , Lee DC (1990). Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121—1135.

26.

Sandgren EP , Luetteke NC , Qiu TH , Palmiter RD , Brinster RL , Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 13: 320—330.

27.

Savion N. , Vlodavsky I. , Gospodarowicz D. (1981). Nuclear accumulation of epidermal growth factor in cultured bovine corneal endothelial and granulosa cells. J Biol Chem 256: 1149—1154.

28.

Steinmetz KL , Klaunig JE (1996). Transforming growth factor-α in carcinogen-induced F344 rat hepatic foci. Toxicol Appl Pharmacol 140: 131—145.

29.

Tanno S. , Ogawa K. (1994). Abundant TGFαprecursor and EGF receptor expression as a possible mechanis m for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis 15:1689—1694.

30.

Turusov VS , Deringer MK , Dunn TB , Stewart HL (1973). Malignantmouseliver tumors resembling human hepatoblastomas . J Natl Cancer Inst 51: 1689—1695.

31.

Yankner BA , Shooter EM (1979). Nerve growth factor in the nucleus: Interaction with receptors on the nuclear membrane. Proc Natl Acad Sci USA 76: 1269—1273.